Last reviewed · How we verify

Calcitonin Gene-Related Peptide

Danish Headache Center · FDA-approved active Small molecule Quality 5/100

Calcitonin Gene-Related Peptide is a Small molecule drug developed by Danish Headache Center. It is currently FDA-approved. Also known as: CGRP.

At a glance

Generic nameCalcitonin Gene-Related Peptide
Also known asCGRP
SponsorDanish Headache Center
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Calcitonin Gene-Related Peptide

What is Calcitonin Gene-Related Peptide?

Calcitonin Gene-Related Peptide is a Small molecule drug developed by Danish Headache Center.

Who makes Calcitonin Gene-Related Peptide?

Calcitonin Gene-Related Peptide is developed and marketed by Danish Headache Center (see full Danish Headache Center pipeline at /company/danish-headache-center).

Is Calcitonin Gene-Related Peptide also known as anything else?

Calcitonin Gene-Related Peptide is also known as CGRP.

What development phase is Calcitonin Gene-Related Peptide in?

Calcitonin Gene-Related Peptide is FDA-approved (marketed).

Related